Trials / Conditions / Myelodysplastic Syndrome/Acute Myeloid Leukemia

Myelodysplastic Syndrome/Acute Myeloid Leukemia

9 registered clinical trials studyying Myelodysplastic Syndrome/Acute Myeloid Leukemia — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients Wi NCT06484062	National Cancer Institute (NCI)	Phase 1
Suspended	Regorafenib in Combination With Venetoclax and Azacitidine for the Treatment of Patients With Relapsed or Refr NCT06454409	City of Hope Medical Center	Phase 1
Recruiting	Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia NCT06357182	OHSU Knight Cancer Institute	Phase 1
Recruiting	A Study to Investigate APL-4098 Alone and in Combination in Adults With AML or MDS NCT06372717	Apollo Therapeutics Ltd	Phase 1
Recruiting	AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia NCT05211570	AB Science	Phase 1 / Phase 2
Withdrawn	Nivolumab for High-Risk MDS/AML Patients After Allogeneic Stem Cell Transplant With Post-Transplant Cyclophosp NCT04361058	SCRI Development Innovations, LLC	Phase 1
Recruiting	Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Bloo NCT03779854	Fred Hutchinson Cancer Center	Phase 2
Completed	Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Pat NCT03092674	National Cancer Institute (NCI)	Phase 2 / Phase 3
Active Not Recruiting	Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic S NCT01522976	National Cancer Institute (NCI)	Phase 2